Marksans Pharma Limited has informed the Exchange about Addendum to the notice of Annual General Meeting.
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has issued an addendum to the notice of its 33rd Annual General Meeting (scheduled for 8 August 2025) proposing one additional Special Resolution (No. 8). The resolution seeks shareholder approval to re-appoint Mr. Mark Saldanha (DIN: 00020983) as Managing Director for a further period of 5 years, effective 6 October 2025, since his current tenure ends on 5 October 2025. His proposed remuneration is Rs. 6 crore per annum (Rs. 50 lakh per month), inclusive of basic salary, allowances, PF, and gratuity, along with perquisites like furnished house, car, and club membership. E-voting for the AGM will run from 5 August (9:00 AM) to 7 August 2025 (5:00 PM). Mr. Saldanha, a Science Graduate with 24+ years of experience, holds 19.84 crore shares in the company and was first appointed to the Board on 6 October 2005.
This is a routine governance/leadership continuity item rather than a strategic event — shareholders are being asked to confirm the promoter's continued leadership for another 5-year term. The disclosed pay (Rs. 6 cr/year) is in line with his last drawn package (Rs. 6.37 cr), so no material cost change is expected. Approval is likely given his large shareholding, and the stock is unlikely to react materially to this disclosure.